Metabotropic Glutamate Receptors for Parkinson's Disease Therapy

by Fabrizio Gasparini, Thérèse Di Paolo, Baltazar Gomez-Mancilla
Published 2013-01-01

Heterogeneity in Fragile X Syndrome Highlights the Need for Precision Medicine-Based Treatments

by Edgard Verdura, Laura Pérez-Cano, Rubén Sabido-Vera, Emre Guney, Emre Guney, Jean-Marc Hyvelin, Lynn Durham, Lynn Durham, Baltazar Gomez-Mancilla, Baltazar Gomez-Mancilla
Published 2021-09-01

Regional brain mGlu5 receptor occupancy following single oral doses of mavoglurant as measured by [11C]-ABP688 PET imaging in healthy volunteers

by Johannes Streffer, Valerie Treyer, Alfred Buck, Simon M. Ametamey, Milen Blagoev, Ralph P Maguire, Aurélie Gautier, Yves P. Auberson, Mark E. Schmidt, Ivan-Toma Vranesic, Baltazar Gomez-Mancilla, Fabrizio Gasparini
Published 2021-04-01

AFQ056, a new mGluR5 antagonist for treatment of fragile X syndrome

by Josien Levenga, Shigemi Hayashi, Femke M.S. de Vrij, Sebastiaan K. Koekkoek, Herma C. van der Linde, Ingeborg Nieuwenhuizen, Cheng Song, Ronald A.M. Buijsen, Andreea S. Pop, Baltazar GomezMancilla, David L. Nelson, Rob Willemsen, Fabrizio Gasparini, Ben A. Oostra
Published 2011-06-01

A Study of Novel Exploratory Tools, Digital Technologies, and Central Nervous System Biomarkers to Characterize Unipolar Depression

by Oleksandr Sverdlov, Jelena Curcic, Kristin Hannesdottir, Liangke Gou, Valeria De Luca, Francesco Ambrosetti, Bingsong Zhang, Jens Praestgaard, Vanessa Vallejo, Andrew Dolman, Baltazar Gomez-Mancilla, Konstantinos Biliouris, Mark Deurinck, Francesca Cormack, John J. Anderson, Nicholas T. Bott, Ziv Peremen, Gil Issachar, Offir Laufer, Dale Joachim, Raj R. Jagesar, Niels Jongs, Martien J. Kas, Ahnjili Zhuparris, Rob Zuiker, Kasper Recourt, Zoë Zuilhof, Jang-Ho Cha, Gabriel E. Jacobs, Gabriel E. Jacobs
Published 2021-05-01